Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals

Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV

(2021) Jake A. Ruddy et al.   AIDS

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

(2021) Nicholas A Kennedy et al.   GUT

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

(2021) Alfredo Addeo et al.   CANCER CELL

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

(2021) Itzchak Levy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

(2021) Deborah Steensels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

More evidence for worse COVID-19 outcomes in people with HIV

(2021) Marta Boffito et al.   Lancet HIV

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

(2021) Xueying Yang et al.   Lancet HIV

Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa

(2020) Andrew Boulle et al.   CLINICAL INFECTIOUS DISEASES

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

(2020) Krishnan Bhaskaran et al.   Lancet HIV

Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients

(2015) A Calmy et al.   HIV MEDICINE